Addus HomeCare Corporation $ADUS Shares Sold by Summit Creek Advisors LLC

Summit Creek Advisors LLC reduced its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 4.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 177,296 shares of the company’s stock after selling 7,586 shares during the period. Addus HomeCare accounts for about 3.0% of Summit Creek Advisors LLC’s holdings, making the stock its 2nd biggest position. Summit Creek Advisors LLC owned about 0.96% of Addus HomeCare worth $19,040,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently modified their holdings of ADUS. Royal Bank of Canada raised its position in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after purchasing an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after purchasing an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Addus HomeCare by 6.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares during the last quarter. Jane Street Group LLC raised its position in shares of Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC raised its position in shares of Addus HomeCare by 44.7% during the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Addus HomeCare

In other news, EVP Sean Gaffney sold 442 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $46,569.12. Following the completion of the sale, the executive vice president directly owned 20,080 shares of the company’s stock, valued at $2,115,628.80. The trade was a 2.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Roberton James Stevenson sold 284 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $29,922.24. Following the sale, the executive vice president directly owned 14,030 shares of the company’s stock, valued at $1,478,200.80. This represents a 1.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 16,788 shares of company stock worth $1,785,633. 4.50% of the stock is owned by corporate insiders.

Addus HomeCare Stock Up 1.3%

ADUS stock opened at $93.76 on Thursday. The stock has a market capitalization of $1.75 billion, a P/E ratio of 17.33, a PEG ratio of 1.27 and a beta of 0.92. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. Addus HomeCare Corporation has a one year low of $89.76 and a one year high of $124.43. The company has a 50 day moving average price of $96.10 and a two-hundred day moving average price of $105.73.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same period in the previous year, the company earned $1.42 EPS. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. As a group, sell-side analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Analysts Set New Price Targets

ADUS has been the subject of several research reports. Royal Bank Of Canada restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday, February 25th. Barclays lowered their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a research note on Friday, May 15th. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.